PE110398A1 - Productos intermedios y proceso para preparar olanzapina - Google Patents

Productos intermedios y proceso para preparar olanzapina

Info

Publication number
PE110398A1
PE110398A1 PE1997000855A PE00085597A PE110398A1 PE 110398 A1 PE110398 A1 PE 110398A1 PE 1997000855 A PE1997000855 A PE 1997000855A PE 00085597 A PE00085597 A PE 00085597A PE 110398 A1 PE110398 A1 PE 110398A1
Authority
PE
Peru
Prior art keywords
olanzapine
polymorph
methyl
refers
intermediate products
Prior art date
Application number
PE1997000855A
Other languages
English (en)
Spanish (es)
Inventor
Arthur Bunnell Charles
Dean Larsen Samuel
Richard Nichols John
Marie Reutzel Susan
Alan Stephenson Gregory
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE110398(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE110398A1 publication Critical patent/PE110398A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE1997000855A 1996-09-23 1997-09-23 Productos intermedios y proceso para preparar olanzapina PE110398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
PE110398A1 true PE110398A1 (es) 1999-01-14

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000855A PE110398A1 (es) 1996-09-23 1997-09-23 Productos intermedios y proceso para preparar olanzapina

Country Status (35)

Country Link
US (1) US6020487A (enExample)
EP (1) EP0831098B1 (enExample)
JP (2) JP2001500877A (enExample)
KR (1) KR100560015B1 (enExample)
CN (1) CN1122036C (enExample)
AR (1) AR013838A1 (enExample)
AT (1) ATE209208T1 (enExample)
AU (1) AU719441B2 (enExample)
BR (1) BR9712100A (enExample)
CA (1) CA2265712C (enExample)
CO (1) CO4910140A1 (enExample)
CZ (1) CZ299248B6 (enExample)
DE (1) DE69708428T2 (enExample)
DK (1) DK0831098T3 (enExample)
EA (1) EA001642B1 (enExample)
EG (1) EG23861A (enExample)
ES (1) ES2166051T3 (enExample)
HU (1) HU226484B1 (enExample)
ID (1) ID27275A (enExample)
IL (1) IL128962A (enExample)
IN (1) IN187156B (enExample)
MY (1) MY125565A (enExample)
NO (1) NO323980B1 (enExample)
NZ (1) NZ334448A (enExample)
PE (1) PE110398A1 (enExample)
PL (3) PL194565B1 (enExample)
PT (1) PT831098E (enExample)
RS (1) RS49598B (enExample)
SI (1) SI0831098T1 (enExample)
SV (1) SV1997000081A (enExample)
TR (1) TR199900640T2 (enExample)
TW (1) TW470746B (enExample)
UA (1) UA59371C2 (enExample)
WO (1) WO1998012199A1 (enExample)
ZA (1) ZA978515B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
EP1440074A1 (en) * 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CA2471341C (en) 2001-12-24 2012-01-24 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
EP1513846B1 (en) * 2002-05-31 2011-03-02 Sandoz Ag Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
WO2005049090A2 (en) * 2003-11-18 2005-06-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
CA2551806A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries, Ltd. Methods of preparing olanzapine
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
AU2005307797B2 (en) * 2004-11-16 2011-06-02 Alkermes Pharma Ireland Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
AU668159B2 (en) * 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
NZ334346A (en) * 1996-09-23 2000-05-26 Lilly Co Eli Olanzapine dihydrate D comprising 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine and a formulation for use in treating central nervous system disorders

Also Published As

Publication number Publication date
HUP0000066A3 (en) 2000-11-28
YU15599A (sh) 2001-12-26
CO4910140A1 (es) 2000-04-24
EP0831098A2 (en) 1998-03-25
ID27275A (id) 2001-03-22
EA199900326A1 (ru) 1999-08-26
EP0831098A3 (en) 1998-04-29
DK0831098T3 (da) 2002-05-21
JP2009242407A (ja) 2009-10-22
RS49598B (sr) 2007-06-04
EA001642B1 (ru) 2001-06-25
ZA978515B (en) 1999-03-23
US6020487A (en) 2000-02-01
DE69708428D1 (de) 2002-01-03
EG23861A (en) 2007-11-18
AU719441B2 (en) 2000-05-11
PL194565B1 (pl) 2007-06-29
HK1009807A1 (en) 1999-06-11
PL196068B1 (pl) 2007-12-31
EP0831098B1 (en) 2001-11-21
PL332482A1 (en) 1999-09-13
CZ99099A3 (cs) 1999-11-17
NO323980B1 (no) 2007-07-30
BR9712100A (pt) 1999-08-31
PL196069B1 (pl) 2007-12-31
UA59371C2 (uk) 2003-09-15
DE69708428T2 (de) 2002-07-04
CA2265712C (en) 2006-10-31
KR20000048520A (ko) 2000-07-25
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
MY125565A (en) 2006-08-30
TW470746B (en) 2002-01-01
HU226484B1 (en) 2009-03-02
JP2001500877A (ja) 2001-01-23
SV1997000081A (es) 1999-01-14
ATE209208T1 (de) 2001-12-15
TR199900640T2 (xx) 1999-06-21
AR013838A1 (es) 2001-01-31
ES2166051T3 (es) 2002-04-01
SI0831098T1 (en) 2002-04-30
CN1122036C (zh) 2003-09-24
CA2265712A1 (en) 1998-03-26
AU4484197A (en) 1998-04-14
PT831098E (pt) 2002-04-29
IN187156B (enExample) 2002-02-16
HUP0000066A2 (hu) 2000-06-28
CZ299248B6 (cs) 2008-05-28
IL128962A0 (en) 2000-02-17
CN1234802A (zh) 1999-11-10
IL128962A (en) 2003-01-12
NO991382D0 (no) 1999-03-22
KR100560015B1 (ko) 2006-03-15
NO991382L (no) 1999-03-22

Similar Documents

Publication Publication Date Title
PE110398A1 (es) Productos intermedios y proceso para preparar olanzapina
ES2112971T3 (es) Procedimiento para el tratamiento de fibras para la fabricacion de papel de seda.
DK0751129T3 (da) Substituerede dihydrodibenz/b,f/azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle li
DE69912606D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
PE110298A1 (es) Dihidrato d de olanzapina
ES2093905T3 (es) Nuevo procedimiento para la obtencion de derivados de la n4-acil-5'-desoxi-5-fluorocitidina.
TR199902538T2 (xx) Yeni bile�imler.
HUT77716A (hu) Eljárás 4a,5,9,10,11,12-hexahidro-6H-benzofuro[3a,3,2ef][2]-benzazepin-származékok előállítására, és egyes ilyen vegyületek
NO903359D0 (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-9-akridinamin-derivater.
ES2091324T3 (es) Proceso para la preparacion de aspartama a partir de una dicetopiperazina y nuevos compuestos intermedios y derivados para dicho proceso.
NO178968C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater
RO77280A (ro) Procedeu pentru prepararea unor izocianati aromatici de inalta puritate
ES2071303T3 (es) Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.
PT91414A (pt) Processo para a preparacao de 2-fenil-1,2-benzisosselenazol-3(2h)-ona(ebseleno) sob uma forma muito pura
PE38197A1 (es) Procedimiento para preparar solvatos de 2-metil-tieno-benzodiacepina (olanzapina)
NO176357C (no) Analogifremgangsmåte for fremstilling av 4,5,7,8-tetrahydro-6H-tiazolo [5,4-dÅ- azepiner
SE8503556D0 (sv) Naphthyl analogs of mevalonolactone and derivatives thereof, processes for their production and their use
EG13590A (en) Process for the production of trans-5-aryl-2,3,4,4a,5,9b-hexahydro-th-pyrido(4,3-b)indoles of use as tranquilizing agents
NO155967C (no) Fremgangsmaate for fremstilling av ergolin ved isomerisering i 8-stillingen.
ES2160768T3 (es) Procedimiento de obtencion de la forma polimorfica i de d4t.
UY23825A1 (es) Procedimiento para la preparación de derivados de pirido [1,2,3-d,e] [1,3,4] benzoxadiazina.-
EG20261A (en) Process for preparing of novel basic - substituted 5-halo- thienoisothiazol -3(2H)- one 1,1-dioxides
HUT46921A (en) Process for producing 3-phenyl-7h-thiazolo /3,2-b//1,2,4/ triazin-7-ones, certain intermediaries thereof and pharmaceutics comprising such active ingredient
BE1002661A3 (fr) Procede pour la fabrication de semi-hydrate de sulfate de calcium.

Legal Events

Date Code Title Description
FG Grant, registration